FDA Approved: FLUPHENAZINE DECANOATE — Supplemental Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

The FDA approved a supplemental application for Fluphenazine Decanoate from Fresenius Kabi USA, LLC, related to its continued use as a long-acting injectable an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Fluphenazine decanoate (Fluphenazine decanoate)

Snippet

SUPPL AP for FLUPHENAZINE DECANOATE (FLUPHENAZINE DECANOATE)